iSpecimen (ISPC) Change in Accured Expenses (2020 - 2026)

iSpecimen's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $24261.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 106.92% year-over-year to $24261.0; the TTM figure through Mar 2026 stood at -$174751.0 (up 80.42% YoY), while the FY2025 annual figure was -$549544.0, down 47.8% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $24261.0, up from -$97636.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $512647.0 in Q4 2023, with the low at -$622926.0 in Q1 2023.
• The 5-year median for Change in Accured Expenses is -$26038.0 (2023), against an average of -$52700.1.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses surged 17567.12% in 2022, then tumbled 2164.65% in 2023.
• iSpecimen's Change in Accured Expenses stood at $116073.0 in 2022, then jumped by 341.66% to $512647.0 in 2023, then slumped by 71.44% to $146413.0 in 2024, then slumped by 166.69% to -$97636.0 in 2025, then soared by 124.85% to $24261.0 in 2026.
• Business Quant data shows ISPC's Change in Accured Expenses at $24261.0 in Q1 2026, -$97636.0 in Q4 2025, and $71311.0 in Q3 2025.